POINT Biopharma Global Inc.
POINT Biopharma Global Inc. (PNT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · PNT · as of Dec 31, 2023
Ownership Breakdown
5
Institutional Holders
▼ 127 vs Q3
$1,000
Total Inst. Value
▼ $411.05M vs Q3
106.57M
Shares Outstanding
freeFloat 82.08%
127
13F Shares Held
▼ 61.63M vs Q3
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
PNT largest shareholders · institutional ownership
Q4 2023 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
LMR PARTNERS LLP pharmaceutical preparations | 518.7K | 49.04% | 49.04% | $6.48B | Feb 14, 2024 | NEW |
JET CAPITAL INVESTORS L P pharmaceutical preparations | 164.6K | 15.56% | 15.56% | $2.06B | Feb 14, 2024 | NEW |
CLEAR STREET MARKETS LLC pharmaceutical preparations | 71.6K | 6.77% | 6.77% | $4.00M | Feb 14, 2024 | NEW |
JET CAPITAL INVESTORS L P pharmaceutical preparations | 2.8K | 0.26% | 0.26% | $35.00M | Feb 14, 2024 | NEW |
RONALD BLUE TRUST, INC. pharmaceutical preparations | 127 | 0.01% | 0.01% | $1.00M | Jan 18, 2024 | NEW |
NORTHERN TRUST CORP pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 13, 2024 | EXIT |
WELLS FARGO & COMPANY/MN pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 9, 2024 | EXIT |
US BANCORP \DE\ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 9, 2024 | EXIT |
VANGUARD GROUP INC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Mar 11, 2024 | EXIT |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Feb 14, 2024 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2023 vs prior quarter
Q4 2023
0
Increased
+0 shares5
New Positions
first time holders0
Decreased
−0 shares45
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
-40
5 new / 45 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
PNT insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
55
Sell transactions
0.00
Buy/Sell ratio
$10M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
GOODMAN JONATHAN R. director | Dec 27, 2023 | D-Return | 44,749 | $9.12 | $408.1K | 0 | Form 4 ↗ |
GOODMAN JONATHAN R. director | Dec 26, 2023 | U-Tender | 41,872 | $12.50 | $523.4K | 0 | Form 4 ↗ |
GOODMAN JONATHAN R. director | Dec 27, 2023 | D-Return | 35,872 | $6.97 | $250.0K | 0 | Form 4 ↗ |
GOODMAN JONATHAN R. director | Dec 27, 2023 | D-Return | 25,000 | $8.47 | $211.8K | 0 | Form 4 ↗ |
GOODMAN JONATHAN R. director | Dec 27, 2023 | D-Return | 25,614 | $8.31 | $212.9K | 0 | Form 4 ↗ |
KELLY JUSTYNA Chief Operating Officer | Dec 27, 2023 | D-Return | 26,904 | $6.97 | $187.5K | 0 | Form 4 ↗ |
KELLY JUSTYNA Chief Operating Officer | Dec 27, 2023 | D-Return | 4,932 | $8.47 | $41.8K | 0 | Form 4 ↗ |
KELLY JUSTYNA Chief Operating Officer | Dec 27, 2023 | D-Return | 77,958 | $8.13 | $633.8K | 0 | Form 4 ↗ |
KELLY JUSTYNA Chief Operating Officer | Dec 27, 2023 | D-Return | 98,358 | $6.78 | $666.9K | 0 | Form 4 ↗ |
KELLY JUSTYNA Chief Operating Officer | Dec 27, 2023 | D-Return | 70,000 | $6.40 | $448.0K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
POINT Biopharma Global Inc. (PNT) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 17.92%, while retail and public investors account for the remaining 82.08%.
The largest institutional shareholder of POINT Biopharma Global Inc. is LMR PARTNERS LLP, holding approximately 518,700 shares — equal to 49.04% of outstanding shares — as of December 31, 2023.
A total of 5 institutional investors currently hold PNT stock, with a combined institutional value of approximately $1,000 as of the most recent 13F filing period.
Frequently asked questions
PNT ownershipPOINT Biopharma Global Inc. (PNT) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is LMR PARTNERS LLP with a 49.04% stake. Company insiders hold 17.92%. Data sourced from SEC Form 13F as of December 31, 2023.